Robert E Reeves
Overview
Explore the profile of Robert E Reeves including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
300
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gowrishankar G, Hardy J, Wardak M, Namavari M, Reeves R, Neofytou E, et al.
J Nucl Med
. 2017 May;
58(10):1679-1684.
PMID: 28490473
6″-F-fluoromaltotriose is a PET tracer that can potentially be used to image and localize most bacterial infections, much like F-FDG has been used to image and localize most cancers. However,...
2.
Natarajan A, Mayer A, Reeves R, Nagamine C, Gambhir S
Mol Imaging Biol
. 2017 Mar;
19(6):903-914.
PMID: 28247187
Purpose: It is well known that cancers exploit immune checkpoints (programmed death 1 receptor (PD-1) and its ligand (PD-L1)) to evade anti-tumor immune responses. Although immune checkpoint (IC) blockade is...
3.
Natarajan A, Mayer A, Xu L, Reeves R, Gano J, Gambhir S
Bioconjug Chem
. 2015 Aug;
26(10):2062-9.
PMID: 26307602
Immune checkpoint signaling through the programmed death 1 (PD-1) axis to its ligand (PD-L1) significantly dampens anti-tumor immune responses. Cancer patients treated with checkpoint inhibitors that block this suppressive signaling...
4.
Witney T, Hoehne A, Reeves R, Ilovich O, Namavari M, Shen B, et al.
Clin Cancer Res
. 2015 May;
21(17):3896-905.
PMID: 25972517
Purpose: An early readout of tumor response to therapy through measurement of drug or radiation-induced cell death may provide important prognostic indications and improved patient management. It has been shown...
5.
Sykes L, Geier D, King P, Kern J, Haley B, Chaigneau C, et al.
Indian J Med Ethics
. 2014 Aug;
11(4):206-18.
PMID: 25101548
When addressing toxins, one unmistakable parallel exists between biology and politics: developing children and developing nations are those most vulnerable to toxic exposures. This disturbing parallel is the subject of...
6.
Chan C, Reeves R, Geller R, Yaghoubi S, Hoehne A, Solow-Cordero D, et al.
Proc Natl Acad Sci U S A
. 2012 Aug;
109(37):E2476-85.
PMID: 22895790
Up-regulation of the folding machinery of the heat-shock protein 90 (Hsp90) chaperone protein is crucial for cancer progression. The two Hsp90 isoforms (α and β) play different roles in response...
7.
Hickerson R, Smith F, Reeves R, Contag C, Leake D, Leachman S, et al.
J Invest Dermatol
. 2007 Oct;
128(3):594-605.
PMID: 17914454
RNA interference offers a novel approach for developing therapeutics for dominant-negative genetic disorders. The ability to inhibit expression of the mutant allele without affecting wild-type gene expression could be a...
8.
Smith F, Hickerson R, Sayers J, Reeves R, Contag C, Leake D, et al.
J Invest Dermatol
. 2007 Sep;
128(1):50-8.
PMID: 17762855
Pachyonychia congenita (PC) is an autosomal-dominant keratin disorder where the most painful, debilitating aspect is plantar keratoderma. PC is caused by mutations in one of four keratin genes; however, most...